{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:27:05Z","timestamp":1768094825682,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFD1802101"],"award-info":[{"award-number":["2022YFD1802101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00394-024-03525-5","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T05:03:45Z","timestamp":1732251825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Xanthohumol ameliorates dextran sodium sulfate-induced colitis in mice by inhibiting of NF-\u03baB signaling pathways and modulating intestinal microbiota"],"prefix":"10.1007","volume":"64","author":[{"given":"Ning","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1103-7170","authenticated-orcid":false,"given":"Zhenling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"30","key":"3525_CR1","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.3748\/wjg.v12.i30.4807","volume":"12","author":"S Danese","year":"2006","unstructured":"Danese S, Fiocchi C (2006) Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 12(30):4807\u20134812","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3525_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.crohns.2013.09.009","volume":"8","author":"DJ Mulder","year":"2014","unstructured":"Mulder DJ, Noble AJ, Justinich CJ, Duffin JM (2014) A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis 8(5):341\u2013348. https:\/\/doi.org\/10.1016\/j.crohns.2013.09.009","journal-title":"J Crohns Colitis"},{"issue":"2","key":"3525_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2468-1253(21)00223-5","volume":"7","author":"K Papamichael","year":"2022","unstructured":"Papamichael K, Afif W, Drobne D, Dubinsky MC, Ferrante M, Irving PM, Kamperidis N, Kobayashi T, Kotze PG, Lambert J, Noor NM, Roblin X, Roda G, Vande Casteele N, Yarur AJ, Arebi N, Danese S, Paul S, Sandborn WJ, Vermeire S, Cheifetz AS, Peyrin-Biroulet L (2022) Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives. Lancet Gastroenterol Hepatol 7(2):171\u2013185. https:\/\/doi.org\/10.1016\/S2468-1253(21)00223-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3525_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","volume":"73","author":"Y Shan","year":"2022","unstructured":"Shan Y, Lee M, Chang EB (2022) The gut Microbiome and Inflammatory Bowel diseases. Annu Rev Med 73:455\u2013468. https:\/\/doi.org\/10.1146\/annurev-med-042320-021020","journal-title":"Annu Rev Med"},{"issue":"1","key":"3525_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40168-021-01115-9","volume":"9","author":"Z Wu","year":"2021","unstructured":"Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S, Zhang G, Zhao J, Wang J (2021) Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome 9(1):184. https:\/\/doi.org\/10.1186\/s40168-021-01115-9","journal-title":"Microbiome"},{"issue":"23","key":"3525_CR6","doi-asserted-by":"publisher","first-page":"10665","DOI":"10.7150\/thno.43528","volume":"10","author":"J Wu","year":"2020","unstructured":"Wu J, Wei Z, Cheng P, Qian C, Xu F, Yang Y, Wang A, Chen W, Sun Z, Lu Y (2020) Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis. Theranostics 10(23):10665\u201310679. https:\/\/doi.org\/10.7150\/thno.43528","journal-title":"Theranostics"},{"issue":"1","key":"3525_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13073-017-0490-5","volume":"9","author":"AB Hall","year":"2017","unstructured":"Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T, Lagoudas GK, Vatanen T, Fornelos N, Wilson R, Bertha M, Cohen M, Garber J, Khalili H, Gevers D, Ananthakrishnan AN, Kugathasan S, Lander ES, Blainey P, Vlamakis H, Xavier RJ, Huttenhower C (2017) A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med 9(1):103. https:\/\/doi.org\/10.1186\/s13073-017-0490-5","journal-title":"Genome Med"},{"key":"3525_CR8","doi-asserted-by":"publisher","unstructured":"Lee JWJ, Plichta D, Hogstrom L, Borren NZ, Lau H, Gregory SM, Tan W, Khalili H, Clish C, Vlamakis H, Xavier RJ, Ananthakrishnan AN (2021) Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe 29(8). https:\/\/doi.org\/10.1016\/j.chom.2021.06.019","DOI":"10.1016\/j.chom.2021.06.019"},{"issue":"1","key":"3525_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.intimp.2014.09.005","volume":"23","author":"L Cui","year":"2014","unstructured":"Cui L, Feng L, Zhang ZH, Jia XB (2014) The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4\/NF-\u03baB pathway activation. Int Immunopharmacol 23(1):294\u2013303. https:\/\/doi.org\/10.1016\/j.intimp.2014.09.005","journal-title":"Int Immunopharmacol"},{"key":"3525_CR10","doi-asserted-by":"crossref","unstructured":"Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107 (1)","DOI":"10.1172\/JCI11830"},{"issue":"10","key":"3525_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2(10):725\u2013734","journal-title":"Nat Rev Immunol"},{"key":"3525_CR12","doi-asserted-by":"publisher","first-page":"115690","DOI":"10.1016\/j.jep.2022.115690","volume":"300","author":"Y Dai","year":"2023","unstructured":"Dai Y, Lu Q, Li P, Zhu J, Jiang J, Zhao T, Hu Y, Ding K, Zhao M (2023) Xianglian pill attenuates ulcerative colitis through TLR4\/MyD88\/NF-\u03baB signaling pathway. J Ethnopharmacol 300:115690. https:\/\/doi.org\/10.1016\/j.jep.2022.115690","journal-title":"J Ethnopharmacol"},{"key":"3525_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13020-020-0296-z","volume":"15","author":"P-D Lu","year":"2020","unstructured":"Lu P-D, Zhao Y-H (2020) Targeting NF-\u03baB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines. Chin Med 15:15. https:\/\/doi.org\/10.1186\/s13020-020-0296-z","journal-title":"Chin Med"},{"issue":"24","key":"3525_CR14","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1021\/jf500426z","volume":"62","author":"M Liu","year":"2014","unstructured":"Liu M, Yin H, Liu G, Dong J, Qian Z, Miao J (2014) Xanthohumol, a prenylated chalcone from beer hops, acts as an \u03b1-glucosidase inhibitor in vitro. J Agric Food Chem 62(24):5548\u20135554. https:\/\/doi.org\/10.1021\/jf500426z","journal-title":"J Agric Food Chem"},{"issue":"3","key":"3525_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.foodchem.2012.03.043","volume":"134","author":"H Hirata","year":"2012","unstructured":"Hirata H, Takazumi K, Segawa S, Okada Y, Kobayashi N, Shigyo T, Chiba H (2012) Xanthohumol, a prenylated chalcone from Humulus lupulus L., inhibits cholesteryl ester transfer protein. Food Chem 134(3):1432\u20131437. https:\/\/doi.org\/10.1016\/j.foodchem.2012.03.043","journal-title":"Food Chem"},{"key":"3525_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.redox.2017.03.001","volume":"12","author":"H Lv","year":"2017","unstructured":"Lv H, Liu Q, Wen Z, Feng H, Deng X, Ci X (2017) Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK\/GSK3\u03b2-Nrf2 signal axis. Redox Biol 12:311\u2013324. https:\/\/doi.org\/10.1016\/j.redox.2017.03.001","journal-title":"Redox Biol"},{"issue":"1","key":"3525_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cas.13441","volume":"109","author":"K Saito","year":"2018","unstructured":"Saito K, Matsuo Y, Imafuji H, Okubo T, Maeda Y, Sato T, Shamoto T, Tsuboi K, Morimoto M, Takahashi H, Ishiguro H, Takiguchi S (2018) Xanthohumol inhibits angiogenesis by suppressing nuclear factor-\u03baB activation in pancreatic cancer. Cancer Sci 109(1):132\u2013140. https:\/\/doi.org\/10.1111\/cas.13441","journal-title":"Cancer Sci"},{"issue":"3","key":"3525_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/mnfr.201100554","volume":"56","author":"L Legette","year":"2012","unstructured":"Legette L, Ma L, Reed RL, Miranda CL, Christensen JM, Rodriguez-Proteau R, Stevens JF (2012) Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration. Mol Nutr Food Res 56(3):466\u2013474. https:\/\/doi.org\/10.1002\/mnfr.201100554","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"3525_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/mnfr.201300333","volume":"58","author":"L Legette","year":"2014","unstructured":"Legette L, Karnpracha C, Reed RL, Choi J, Bobe G, Christensen JM, Rodriguez-Proteau R, Purnell JQ, Stevens JF (2014) Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Mol Nutr Food Res 58(2):248\u2013255. https:\/\/doi.org\/10.1002\/mnfr.201300333","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"3525_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.25122\/jml-2023-0016","volume":"16","author":"SMH Hadi","year":"2023","unstructured":"Hadi SMH, Majeed S, Ghafil FA, Altoraihi K, Hadi NR (2023) Xanthohumol ameliorates cardiac injury induced by sepsis in a mice model: role of toll-like receptor 4. J Med Life 16(7):1105\u20131110. https:\/\/doi.org\/10.25122\/jml-2023-0016","journal-title":"J Med Life"},{"issue":"8","key":"3525_CR21","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1007\/s00394-022-02964-2","volume":"61","author":"F Jung","year":"2022","unstructured":"Jung F, Staltner R, Tahir A, Baumann A, Burger K, Halilbasic E, Hellerbrand C, Bergheim I (2022) Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs. Eur J Nutr 61(8):4155\u20134166. https:\/\/doi.org\/10.1007\/s00394-022-02964-2","journal-title":"Eur J Nutr"},{"issue":"7","key":"3525_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF (2017) Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc 12(7):1295\u20131309. https:\/\/doi.org\/10.1038\/nprot.2017.044","journal-title":"Nat Protoc"},{"key":"3525_CR23","doi-asserted-by":"publisher","unstructured":"Shin AE, Tesfagiorgis Y, Larsen F, Derouet M, Zeng PYF, Good HJ, Zhang L, Rubinstein MR, Han YW, Kerfoot SM, Nichols AC, Hayakawa Y, Howlett CJ, Wang TC, Asfaha S (2023) F4\/80\u2009+\u2009Ly6Chigh macrophages lead to cell plasticity and Cancer initiation in colitis. Gastroenterology 164(4). https:\/\/doi.org\/10.1053\/j.gastro.2023.01.002","DOI":"10.1053\/j.gastro.2023.01.002"},{"issue":"8","key":"3525_CR24","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1002\/ptr.7819","volume":"37","author":"P Jiang","year":"2023","unstructured":"Jiang P, Zhang Y, Li X, Chen J (2023) Geniposidic acid attenuates DSS-induced colitis through inhibiting inflammation and regulating gut microbiota. Phytother Res 37(8):3453\u20133466. https:\/\/doi.org\/10.1002\/ptr.7819","journal-title":"Phytother Res"},{"issue":"3","key":"3525_CR25","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ismej.2011.139","volume":"6","author":"D McDonald","year":"2012","unstructured":"McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P (2012) An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 6(3):610\u2013618. https:\/\/doi.org\/10.1038\/ismej.2011.139","journal-title":"ISME J"},{"issue":"6","key":"3525_CR26","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12(6):R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60","journal-title":"Genome Biol"},{"key":"3525_CR27","doi-asserted-by":"publisher","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do K-A, Peterson CB, Nejman D, Tzeng C-WD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F (2019) Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer outcomes. Cell 178(4). https:\/\/doi.org\/10.1016\/j.cell.2019.07.008","DOI":"10.1016\/j.cell.2019.07.008"},{"key":"3525_CR28","doi-asserted-by":"publisher","first-page":"100178","DOI":"10.1016\/j.mtbio.2021.100178","volume":"13","author":"R Chen","year":"2022","unstructured":"Chen R, Zhou R, Qiao J, Yang Y, Zhou X, Bai R, Wang Y, Yan L, Wu C (2022) Orally administered Bi2S3@SiO2 core-shell nanomaterials as gastrointestinal contrast agents and their influence on gut microbiota. Mater Today Bio 13:100178. https:\/\/doi.org\/10.1016\/j.mtbio.2021.100178","journal-title":"Mater Today Bio"},{"key":"3525_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","volume":"28","author":"A Kaser","year":"2010","unstructured":"Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu Rev Immunol 28:573\u2013621. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101225","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3525_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/nyas.13414","volume":"1401","author":"B-J Guo","year":"2017","unstructured":"Guo B-J, Bian Z-X, Qiu H-C, Wang Y-T, Wang Y (2017) Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Ann N Y Acad Sci 1401(1):37\u201348. https:\/\/doi.org\/10.1111\/nyas.13414","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3525_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.crohns.2013.08.006","volume":"8","author":"V Singla","year":"2014","unstructured":"Singla V, Pratap Mouli V, Garg SK, Rai T, Choudhury BN, Verma P, Deb R, Tiwari V, Rohatgi S, Dhingra R, Kedia S, Sharma PK, Makharia G, Ahuja V (2014) Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study. J Crohns Colitis 8(3):208\u2013214. https:\/\/doi.org\/10.1016\/j.crohns.2013.08.006","journal-title":"J Crohns Colitis"},{"key":"3525_CR32","doi-asserted-by":"publisher","first-page":"1083788","DOI":"10.3389\/fimmu.2022.1083788","volume":"13","author":"C Zhu","year":"2022","unstructured":"Zhu C, Li K, Peng X-X, Yao T-J, Wang Z-Y, Hu P, Cai D, Liu H-Y (2022) Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy. Front Immunol 13:1083788. https:\/\/doi.org\/10.3389\/fimmu.2022.1083788","journal-title":"Front Immunol"},{"key":"3525_CR33","doi-asserted-by":"publisher","first-page":"114749","DOI":"10.1016\/j.jep.2021.114749","volume":"283","author":"X Wang","year":"2022","unstructured":"Wang X, Xie L, Long J, Liu K, Lu J, Liang Y, Cao Y, Dai X, Li X (2022) Therapeutic effect of baicalin on inflammatory bowel disease: a review. J Ethnopharmacol 283:114749. https:\/\/doi.org\/10.1016\/j.jep.2021.114749","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"3525_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT (2017) Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 14(10):573\u2013584. https:\/\/doi.org\/10.1038\/nrgastro.2017.88","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"3525_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai J, Sun L, Gonzalez FJ (2022) Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe 30(3):289\u2013300. https:\/\/doi.org\/10.1016\/j.chom.2022.02.004","journal-title":"Cell Host Microbe"},{"issue":"2","key":"3525_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","volume":"134","author":"RB Sartor","year":"2008","unstructured":"Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134(2):577\u2013594. https:\/\/doi.org\/10.1053\/j.gastro.2007.11.059","journal-title":"Gastroenterology"},{"issue":"7","key":"3525_CR37","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.14309\/ajg.0000000000000305","volume":"114","author":"NC Knox","year":"2019","unstructured":"Knox NC, Forbes JD, Peterson C-L, Van Domselaar G, Bernstein CN (2019) The gut Microbiome in Inflammatory Bowel Disease: lessons learned from other Immune-mediated inflammatory diseases. Am J Gastroenterol 114(7):1051\u20131070. https:\/\/doi.org\/10.14309\/ajg.0000000000000305","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3525_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","volume":"145","author":"KL Glassner","year":"2020","unstructured":"Glassner KL, Abraham BP, Quigley EMM (2020) The microbiome and inflammatory bowel disease. J Allergy Clin Immunol 145(1):16\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.003","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3525_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.gastro.2021.09.061","volume":"162","author":"SF Lima","year":"2022","unstructured":"Lima SF, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin W-B, Pires S, Guo C-J, Gerardin Y, Crawford CV, Jacob V, Scherl E, Brown S-E, Hambor J, Longman RS (2022) Transferable immunoglobulin A-Coated Odoribacter splanchnicus in responders to fecal microbiota transplantation for ulcerative colitis limits colonic inflammation. Gastroenterology 162(1):166\u2013178. https:\/\/doi.org\/10.1053\/j.gastro.2021.09.061","journal-title":"Gastroenterology"},{"issue":"2","key":"3525_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP, Bickley C, Peters C, Schoeman MN, Conlon MA, Roberts-Thomson IC, Andrews JM (2019) Effect of fecal microbiota transplantation on 8-Week remission in patients with Ulcerative Colitis: a Randomized Clinical Trial. JAMA 321(2):156\u2013164. https:\/\/doi.org\/10.1001\/jama.2018.20046","journal-title":"JAMA"},{"key":"3525_CR41","doi-asserted-by":"publisher","first-page":"115005","DOI":"10.1016\/j.biopha.2023.115005","volume":"165","author":"SE Elkholy","year":"2023","unstructured":"Elkholy SE, Maher SA, Abd El-Hamid NR, Elsayed HA, Hassan WA, Abdelmaogood AKK, Hussein SM, Jaremko M, Alshawwa SZ, Alharbi HM, Imbaby S (2023) The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-\u03baB and p38-MAPK pathway. Biomed Pharmacother 165:115005. https:\/\/doi.org\/10.1016\/j.biopha.2023.115005","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3525_CR42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ptr.6866","volume":"35","author":"P Dejban","year":"2021","unstructured":"Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A, Rashidian A (2021) The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4\/NF-kappaB pathway. Phytother Res 35(2):835\u2013845. https:\/\/doi.org\/10.1002\/ptr.6866","journal-title":"Phytother Res"},{"issue":"1","key":"3525_CR43","doi-asserted-by":"publisher","first-page":"866","DOI":"10.18632\/oncotarget.23183","volume":"9","author":"J-M Cho","year":"2018","unstructured":"Cho J-M, Yun S-M, Choi Y-H, Heo J, Kim N-J, Kim S-H, Kim E-H (2018) Xanthohumol prevents dextran sulfate sodium-induced colitis via inhibition of IKK\u03b2\/NF-\u03baB signaling in mice. Oncotarget 9(1):866\u2013880. https:\/\/doi.org\/10.18632\/oncotarget.23183","journal-title":"Oncotarget"},{"issue":"2","key":"3525_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1517\/13543784.2016.1126247","volume":"25","author":"M Berns","year":"2016","unstructured":"Berns M, Hommes DW (2016) Anti-TNF-\u03b1 therapies for the treatment of Crohn\u2019s disease: the past, present and future. Expert Opin Investig Drugs 25(2):129\u2013143. https:\/\/doi.org\/10.1517\/13543784.2016.1126247","journal-title":"Expert Opin Investig Drugs"},{"key":"3525_CR45","doi-asserted-by":"publisher","first-page":"932412","DOI":"10.3389\/fimmu.2022.932412","volume":"13","author":"SH Choi","year":"2022","unstructured":"Choi SH, Huang AY, Letterio JJ, Kim B-G (2022) Smad4-deficient T cells promote colitis-associated colon cancer via an IFN-\u03b3-dependent suppression of 15-hydroxyprostaglandin dehydrogenase. Front Immunol 13:932412. https:\/\/doi.org\/10.3389\/fimmu.2022.932412","journal-title":"Front Immunol"},{"issue":"1","key":"3525_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJMc1915042","volume":"382","author":"CR Rowan","year":"2020","unstructured":"Rowan CR, Boland K, Harewood GC (2020) Ustekinumab as induction and maintenance therapy for Ulcerative Colitis. N Engl J Med 382(1):91. https:\/\/doi.org\/10.1056\/NEJMc1915042","journal-title":"N Engl J Med"},{"issue":"10","key":"3525_CR47","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1021\/jm8016317","volume":"52","author":"JFM Ruiz","year":"2009","unstructured":"Ruiz JFM, Radics G, Windle H, Serra HO, Simpl\u00edcio AL, Kedziora K, Fallon PG, Kelleher DP, Gilmer JF (2009) Design, synthesis, and pharmacological effects of a cyclization-activated steroid prodrug for colon targeting in inflammatory bowel disease. J Med Chem 52(10):3205\u20133211. https:\/\/doi.org\/10.1021\/jm8016317","journal-title":"J Med Chem"},{"issue":"20","key":"3525_CR48","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.1021\/jm1007006","volume":"53","author":"M Larrosa","year":"2010","unstructured":"Larrosa M, Tom\u00e9-Carneiro J, Y\u00e1\u00f1ez-Gasc\u00f3n MJ, Alc\u00e1ntara D, Selma MV, Beltr\u00e1n D, Garc\u00eda-Conesa MT, Urb\u00e1n C, Lucas R, Tom\u00e1s-Barber\u00e1n F, Morales JC, Esp\u00edn JC (2010) Preventive oral treatment with resveratrol pro-prodrugs drastically reduce colon inflammation in rodents. J Med Chem 53(20):7365\u20137376. https:\/\/doi.org\/10.1021\/jm1007006","journal-title":"J Med Chem"},{"issue":"6","key":"3525_CR49","doi-asserted-by":"publisher","first-page":"e2100831","DOI":"10.1002\/mnfr.202100831","volume":"66","author":"HF Neumann","year":"2022","unstructured":"Neumann HF, Frank J, Venturelli S, Egert S (2022) Bioavailability and Cardiometabolic effects of Xanthohumol: evidence from animal and human studies. Mol Nutr Food Res 66(6):e2100831. https:\/\/doi.org\/10.1002\/mnfr.202100831","journal-title":"Mol Nutr Food Res"},{"key":"3525_CR50","doi-asserted-by":"publisher","unstructured":"Yun S-M, Han Y-M, Song M-Y, Lee D-Y, Kim HS, Kim S-H, Kim E-H (2022) Xanthohumol interferes with the activation of TGF-\u03b2 signaling in the process leading to Intestinal Fibrosis. Nutrients 15(1). https:\/\/doi.org\/10.3390\/nu15010099","DOI":"10.3390\/nu15010099"},{"key":"3525_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.abb.2016.03.008","volume":"599","author":"CL Miranda","year":"2016","unstructured":"Miranda CL, Elias VD, Hay JJ, Choi J, Reed RL, Stevens JF (2016) Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL\/6J mice. Arch Biochem Biophys 599:22\u201330. https:\/\/doi.org\/10.1016\/j.abb.2016.03.008","journal-title":"Arch Biochem Biophys"},{"key":"3525_CR52","doi-asserted-by":"publisher","first-page":"1291990","DOI":"10.3389\/fimmu.2023.1291990","volume":"14","author":"EP Karmele","year":"2023","unstructured":"Karmele EP, Moldoveanu AL, Kaymak I, Jugder B-E, Ursin RL, Bednar KJ, Corridoni D, Ort T (2023) Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models. Front Immunol 14:1291990. https:\/\/doi.org\/10.3389\/fimmu.2023.1291990","journal-title":"Front Immunol"},{"issue":"6","key":"3525_CR53","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/ecco-jcc\/jjv050","volume":"9","author":"K Holgersen","year":"2015","unstructured":"Holgersen K, Kutlu B, Fox B, Serikawa K, Lord J, Hansen AK, Holm TL (2015) High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis. J Crohns Colitis 9(6):492\u2013506. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv050","journal-title":"J Crohns Colitis"},{"issue":"3","key":"3525_CR54","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/0023677217742681","volume":"52","author":"M Hoffmann","year":"2018","unstructured":"Hoffmann M, Schwertassek U, Seydel A, Weber K, Falk W, Hauschildt S, Lehmann J (2018) A refined and translationally relevant model of chronic DSS colitis in BALB\/c mice. Lab Anim 52(3):240\u2013252. https:\/\/doi.org\/10.1177\/0023677217742681","journal-title":"Lab Anim"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-024-03525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-024-03525-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-024-03525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T14:25:48Z","timestamp":1739629548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-024-03525-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3525"],"URL":"https:\/\/doi.org\/10.1007\/s00394-024-03525-5","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"21"}}